2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | Tendency/ P-value | |
---|---|---|---|---|---|---|---|---|
Normal | 61,006 96.95% | 57,380 97.53% | 58,857 97.83% | 49,728 97.95% | 52,213 97.71% | 47,459 97.46% | 42,257 97.09% | Z = 1.30 P = 0.072 |
ASC | 1031 1.64% | 843 1.43% | 630 1.05% | 544 1.07% | 723 1.35% | 796 1.63% | 712 1.64% | Z = 1.62 P = 0.106 |
LSIL | 382 0.61% | 263 0.45% | 187 0.31% | 134 0.26% | 187 0.35% | 173 0.36% | 268 0.62% | Z = (−)2.07 P = 0.039 |
HSIL-CIN2 | 113 0.18% | 98 0.17% | 69 0.11% | 36 0.07% | 68 0.13% | 46 0.09% | 63 0.14% | Z = (−)3.28 P = 0.001 |
HSIL-CIN3 | 85 0.14% | 46 0.08% | 51 0.08% | 32 0.06% | 74 0.14% | 57 0.12% | 70 0.16% | Z = 2.32 P = 0.02 |
AGC | 28 0.04% | 23 0.04% | 11 0.02% | 7 0.01% | 9 0.02% | 12 0.02% | 21 0.05% | Z = (−)0.96 P = 0.337 |
AIS | 1 0.00% | 4 0.01% | 2 0.00% | 0 0.00% | 0 0.00% | 0 0.00% | 1 0.00% | Z = (−)1.46 P = 0.143 |
SCC | 7 0.01% | 1 0.00% | 6 0.01% | 8 0.02% | 10 0.02% | 5 0.01% | 5 0.01% | Z = 1.21 P = 0.228 |
Adenoca | 8 0.01% | 9 0.02% | 2 0.00% | 5 0.01% | 6 0.01% | 1 0.00% | 3 0.01% | Z = (−)1.68 P = 0.094 |
Other neoplasias | 0 0.00% | 0 0.00% | 0 0.00% | 0 0.00% | 2 0.00% | 1 0.00% | 0 0.00% | Z = 1.36 P = 0.173 |
No result | 264 0.42% | 167 0.28% | 345 0.57% | 277 0.55% | 146 0.27% | 147 0.30% | 123 0.28% | Z = (−)4.37 P < 0.001 |
Total | 62,925 | 58,834 | 60,160 | 50,771 | 53,438 | 48,697 | 43,523 |